E-LIB Suche - Ergebnisse für: Behrle, J.

1

PIT6 Risk Factors and Incidence Following an INDEX HIP Frac..:

Gunja, N. ; Iglesias, M. ; Behrle, J...
Value in Health. 23 (2020) - p. S575 , 2020

Link: https://doi.org/10.1016/..

2

PSU35 COMPLICATIONS AND REIMBURSEMENT AMONG PATIENTS WITH H..:

Behrle, J. ; Chitnis, A.S. ; Gudiboina, S....
Value in Health. 22 (2019) - p. S898 , 2019

Link: https://doi.org/10.1016/..

3

PSU34 COMPLICATIONS AND REIMBURSEMENT AMONG PATIENTS WITH H..:

Chitnis, A.S. ; Behrle, J. ; Gudiboina, S....
Value in Health. 22 (2019) - p. S898 , 2019

Link: https://doi.org/10.1016/..

4

Higgs mode in a strongly interacting fermionic superfluid:

Behrle, A. ; Harrison, T. ; Kombe, J....
Nature Physics. 14 (2018) 8 - p. 781-785 , 2018

Link: https://doi.org/10.1038/..

5

The pharmacokinetics and safety of desvenlafaxine in subjec..:

Nichols, A.I. ; Richards, L.S. ; Behrle, J.A....
Int. Journal of Clinical Pharmacology and Therapeutics. 49 (2011) 1 - p. 3-13 , 2011

Link: https://doi.org/10.5414/..

6

PI-68Bioavailability and pharmacokinetics of desvenlafaxine..:

RICHARDS, L ; PLOTKA, A ; BEHRLE, J..
Clinical Pharmacology & Therapeutics. 79 (2006) 2 - p. P25-P25 , 2006

Link: https://doi.org/10.1016/..

7

PI-73Effects of chronic hepatic impairment on the pharmacok..:

BAIRDBELLAIRE, S ; PATAT, A ; FAUCHOUX, N...
Clinical Pharmacology & Therapeutics. 79 (2006) 2 - p. P26-P26 , 2006

Link: https://doi.org/10.1016/..

8

An ascending multiple-dose study of the safety and pharmaco..:

RICHARDS, L ; BEHRLE, J ; NICHOLS, A..
Clinical Pharmacology & Therapeutics. 77 (2005) 2 - p. P84-P84 , 2005

Link: https://doi.org/10.1016/..

9

An open-label, randomized, crossover study of the relative ..:

NICHOLS, A ; PATAT, A ; BAIRDBELLAIRE, S..
Clinical Pharmacology & Therapeutics. 77 (2005) 2 - p. P86-P86 , 2005

Link: https://doi.org/10.1016/..

10

The absolute bioavailability of an oral sustained-release f..:

PARKER, V ; RICHARDS, L ; NICHOLS, A..
Clinical Pharmacology & Therapeutics. 77 (2005) 2 - p. P47-P47 , 2005

Link: https://doi.org/10.1016/..

11

Safety, pharmacokinetics (Pk) and pharmacodynamics (PD) of ..:

PARKS, V ; PATAT, A ; BEHRLE, J..
Clinical Pharmacology & Therapeutics. 77 (2005) 2 - p. P44-P44 , 2005

Link: https://doi.org/10.1016/..

12

Safety, pharmacokinetics (PK) and pharmacodynamics (PD) of ..:

PARKS, V ; PATAT, A ; BEHRLE, J..
Clinical Pharmacology & Therapeutics. 77 (2005) 2 - p. P28-P28 , 2005

Link: https://doi.org/10.1016/..

13

An open-label, randomized, single-dose, dose-proportionalit..:

BEHRLE, J ; NICHOLS, A ; MCGRORY, S.
Clinical Pharmacology & Therapeutics. 77 (2005) 2 - p. P82-P82 , 2005

Link: https://doi.org/10.1016/..

14

Annual Survey of American Chemistry. Vol. III. July 1, 1927..:

Behrle
Angewandte Chemie. 42 (1929) 34 - p. 861-861 , 1929

Link: https://doi.org/10.1002/..

15

Contemporary developments in chemistry. Lectures delivered ..:

Behrle
Angewandte Chemie. 41 (1928) 52 - p. 1371-1372 , 1928

Link: https://doi.org/10.1002/..